Hims rises as FDA considers broader peptides access; analysts see long-term win - Reuters

Reuters — Apr 16, 15:35 PM

Read full article at Reuters →

Hims & Hers Rallies on Peptides

• RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves CNBC — Apr 16, 17:44 PM
• How RFK Jr. Sent Hims & Hers Stock Higher Barrons — Apr 16, 12:46 PM
• Hims & Hers Health Stock Rallies on Regulatory Pivot. It’s Not About GLP-1s This Time. Barrons — Apr 16, 12:46 PM